47.15EUR-0.95%Mkt Cap: 2.54B $P/E: 17.591d ago
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland,…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Avg
P/B
Pricier
Div Yield
Avg
1M Perf
Higher
Indicators:|
Key Statistics
Company
Market Cap2.54B $
Enterprise Value3.64B $
Revenue (TTM)1.29B $
Gross Profit851.01M $
Net Income (TTM)143.93M $
Revenue/Share23.88 USD
Last Price47.15 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.5K
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINDE000A2GS5D8
Valuation
P/E (Trailing)17.59
P/E (Forward)16.11
PEG—
EV/EBITDA12.33
EV/Revenue2.83
P/S1.98
P/B3.43
EPS (TTM)2.68
EPS (Forward)2.93
52W Range
31.7076% of range51.90
52W High51.90 EUR
52W Low31.70 EUR
Profitability
Gross Margin67.21%
Oper. Margin19.68%
EBITDA Margin22.96%
Profit Margin11.37%
ROE19.07%
ROA6.06%
Growth
Revenue Growth1.30%
Earnings Growth35.50%
Cash Flow & Leverage
Operating CF249.07M $
CapEx (TTM)45.78M $
FCF Margin13.56%
FCF Yield6.86%
Net Debt884.28M $
Net Debt/EBITDA3.00
Balance Sheet
Debt/Equity1.52
Current Ratio2.00
Quick Ratio0.93
Book Value/Sh13.73 EUR
Cash/Share4.199 EUR
Dividends
Fwd Div Rate0.8800 EUR
Trail. Div Rate0.8800 EUR
Div. Yield1.87%
5Y Avg Yield2.80%
Payout Ratio33.58%
Ex-Div DateJun 29, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)50.38 EUR
Upside (mean)+6.8%
Target Range44.00 EUR – 60.00 EUR
€44.00+6.8% to mean€60.00
# Analysts4
Ownership
Shares Out.49.54M
Float7.04M
Insiders89.30%
Institutions10.39%
Technical
SMA 5047.41 (-0.6%)
SMA 20039.92 (+18.1%)
Beta0.88
S&P 52W Chg20.05%
Avg Vol (30d)22.44K
Avg Vol (10d)31.73K
Technical Indicators
RSI (14)49.0
MACD-0.1083
MACD Signal-0.0194
MACD Hist.-0.0889
BB Upper48.80 EUR
BB Middle47.33 EUR
BB Lower45.86 EUR
BB Width6.21%
ATR (14)1.253 EUR
Vol Ratio (20d)0.53x